胡黄莲苷Ⅱ对脑缺血损伤后细胞凋亡及CytC和Calpain基因表达的影响
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:研究胡黄连营Ⅱ(Picroside Ⅱ)对大鼠脑缺血损伤后神经细胞凋亡以及细胞色素C(CytC)和卡配因(Calpain)基因表达的影响,探讨其治疗脑缺血的作用机制。
     方法:大鼠大脑中动脉阻塞(MCAO)再灌注模型应用线栓法建立,缺血2h经腹腔注射Picroside Ⅱ注射液(10mg/kg)干预治疗,Bederson评分评价大鼠脑缺血2h再灌注2h、6h、12h、24h、2d、3d、7d和14d时间点神经行为功能的变化,原位末端标记(TUNEL)方法观察细胞凋亡,原位杂交技术观察CytC mRNA和Calpain mRNA的表达。
     结果:(1)脑缺血再灌流后3d开始,大鼠神经行为功能逐渐恢复,治疗组与对照组比较,再灌注7-14d有显著性差异。(2)脑缺血再灌注后2h,皮层和纹状体区即出现凋亡神经细胞,随时间延长逐渐增多,分别于1d和2d达到高峰,之后逐渐减少,再灌注14d接近假手术组水平。经Picrosidell治疗后,细胞凋亡数量明显减少,其中再灌注12-7d与对照组比较差异显著。(3)CytC mRNA表达于脑缺血再灌注后2h逐渐出现,皮层区12h达高峰,纹状体区1d达高峰,以后逐渐下降,7d、14d明显减少,但仍显著高于假手术组。再灌流12h及以后时间点,Picroside Ⅱ治疗组CytC mRNA在皮层和纹状体区的表达均显著低于对照组。(4)皮层区和纹状体区Calpain mRNA表达于脑缺血再灌注后2h逐渐出现,再灌注6h明显增加,皮层区12h达高峰;纹状体区1d达高峰,以后逐渐降低。Picroside Ⅱ治疗组再灌注12h及以后时间点,Calpain mRNA在皮层区和纹状体区的表达较对照组有显著降低。
     结论:脑缺血损伤后CytC和Calpain基因表达的时序和区域一致,并先于凋亡细胞而出现,提示CytC和Calpain表达可能是细胞凋亡发生的关键环节。Picroside可下调CytC和Calpain基因表达,提示其具有神经保护作用。
Objective:To investigate the effects of picroside Ⅱ on neuronal apoptosis and gene expressions of cytochrome c (CytC) and calpain in neurons after cerebral ischemia in rats, and to explore the neuroprotective mechanisms of picroside Ⅱ.
     Methods:The model of focal ischemia in Wistar rats was induced by intraluminal middle cerebral artery occlusion (MCAO) with a nylon monofilament suture. Picroside Ⅱ (10mg/kg) was injected intraperitoneally2hours after cerebral ischemia. The neurological function scores were determined by Bederson's method. Apoptosis was characterized by terminal deoxynucleotidyl transferase-mediated uridine5'-triphosphate-biotin nick end-labeling (TUNEL) staining. In situ hybridization was performed to examine the expressions of Cyt C and calpain mRNA in cortex and striatum.
     Results:(1) The neurological behavioral function recovered gradually from reperfusion3d, and significantly at7-14d compared with sham group.(2) TUNEL-positive cells were observed2h after reperfusion in and peaked at1and2d afte reperfusion in cortex and striatum respectively. Picroside Ⅱ decreased the number of TUNEL-positive cells at and after12h after reperfusion.(3) The expressions of CytC and calpain mRNA were weakly in shame-operated group and were detected in cortex and striatum of ischemic hemisphere as early as2h after reperfusion and reached a peak at12h in cortex and1d in striatum respectively. Picroside treatment diminished the CytC and calpain mRNA expressions at and after reperfusion12h.
     Conclusions:These results indicate that picroside II might promote neurological function recovery by means of inhibiting ischemic neuronal apoptosis and by inhibiting gene expression of CytC and calpain. It may be a potential compound in treating stroke.
引文
1. Weiller C, Chollet F, Friston DJ, et al. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol,1992,31:463-472.
    2. Schulz JB,Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol,1999,45(4):421-429
    3. Fujimura M, Morita-Fujimura Y, et al. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab,1998,18(11): 1239-1247
    4. Reed JC, Jurgensmeier JM, Mats uyama S, et al. Bcl-2 family proteins and mitochondria. Biochem Biophys Acta,1998,1366(1-2):127-37
    5. Carafoli E, Molinari M. Calpain:a protease in search of a function? Biochem Biophys Res Commun,1998,247(2):193-203
    6. Blomgren K, Hallin U, Andersson AL, et al. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia ischemia. J Biol Chem,1999,274(20):14046-14052
    7. Guo YL, Xu XY, Li Q, et al. Anti-inflammation effects of Picroside Ⅱ in cerebral ischemic injury rats. Behavioral Brain Function,2010,6:43-49.
    8. Li Q, Li Z, Xu XY, et al. Neuroprotective properties of picroside II in rat model of focal cerebral ischemia. Int J Mol Sci,2010,11(11):4580-4590.
    9. Koizumi J, Yoshida Y, Nakazawa T, et al. Experimental studies of ischemic brain edema:A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke,1986,8(1):1-8
    10. Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion:evaluation of the model and development of a neurologic examination. Stroke,1986,17(3): 472-476
    11. Tseng, EE. Brock MV, Lange MS, et al., Neuronal nitric oxide synthase inhibition reduces neuronal apoptosis after hypothermic circulatory arrest. Ann Thorac Surg, 1997,64(6):1639-1647.
    12. Sugawara T, Fujimura M, Morita-Fujimura Y, et al. Mitochodrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral schemia. J Neurosci,1999,19(22):1-6.
    13. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2:release of cytochrome c from mitochondria blocked. Science,1997,275(5303):1129-1132
    14. Zhivotosky B, Orrenius S, Brustugun OT, et al. Injected cytochrome c induces apoptosis. Nature,1998,391(6666):449-450
    15. Kluck RM, Bossy-Wezel E, Green DR, et al. The release of cytochrome c from mitochondria a primary site for Bcl-2 regulation of apoptosis. Science,1997,275 (5303):1132-1136
    16. Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell,1996,86(1):147-157
    17. Ott M, Robertson JD, Gogvadze V, et al. Cytochrome c release from mitochondria proceeds by a two-step process [J]. Proc Natl Acad Sci USA,2002,99(3):1259-1263
    18. Rosse T, Olivier R, Monney L, et al. Bcl-2 prolongs cell survial after Bax-induced release of cytochrome c. [J]. Nature,1998,391(6666):496-499
    19. Bartus RT, Dean RL, Mennerick S, et al. Temporal ordering of pathogenic events following transient global ischemia. Brain Res,1998,790(1-2):1-13
    20. Bartus RT, Dean RL, Cavanaugh K, et al. Time-related neuronal changes following middle cerebral artery occlusion:implacations for therapeutic intervention and the role of calpain. J Cereb Blood Flow Metab,1995,15(6):969-9
    21. Squier MK, Miller AC, Malkinson AM, et al. Calpain activation in apoptosis. J Cell Physiol,1994,159(2):229-237
    22. Wolf BB, Goldstein JC, Stennicke HR, et al. Calpain functions in a caspase independent manner to promote apoptosis-like events during platelet actavation. Blood,1999,94(5):1683-1692
    23. Lankiewicz S, Marc Luetjens C, True Bui N, et al. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death. J Biol Chem,2000, 275(22):17064-17071
    24. Minn AJ, Velez P, Schendel SL, et al. Bcl-xl forms an ion channel in synthetic lipid membranes [J]. Nature,1997,385(6614):353-357
    25.郭明川,曹艳,刘建文.胡黄连苷Ⅱ在谷氨酸诱导的PCI2细胞损伤中的保护作用[J].中国临床药理学与治疗学,2007,12(4):440-443.
    26.刘建文,魏东芝,等.胡黄连苷Ⅱ在体外对PC12神经细胞损伤的保护作用[J]Chin J Clin Pharmacol Ther,2003,8(1):27-30.
    27.银建军,杨建军,杜芳.胡黄连对缺血再灌注大鼠脑内NMDAR1mRNA表达的影响[J].青岛大学医学院学报,2008,42(7):24-31.
    28.杨学伟,季旭明,郭云良等.胡黄连对大鼠缺血脑组织神经营养因子的影响[J].青岛大学医学院学报,2008,44(1):69-71.
    29。银建军,张伟,杜芳.胡黄连提取物对大鼠脑缺血再灌注后半暗带区细胞凋亡及Bcl-2基因表达的影响[J].山东中医杂志,2005,24(6):364-366.
    30.李震,李晓丹,张睿,等。胡黄连苷对大鼠脑缺血再灌注损伤NFκB和IκB的干预作用.中国药理学通报,2010,26(1):52-56.IF=1.892
    31.李琴,李震,郭云良,等。胡黄连苷对大鼠脑缺血再灌注损伤Caspase-9和PARP干预作用.中国药理学通报,2010,26(3):342-345.IF=1.892
    32.何薇,林江涛.中药胡黄连的化学成分和药理作用的研究进展[J].中日友好医院学报,2005,19(6):369-370.
    33.郭云良,沈卫,李震,等.胡黄连苷Ⅱ对脑缺血再灌注损伤TLR4和NFκB表达的影响.中国中西医结合杂志,2011,31(1):58-61.
    34.李震,秦丽华,郭云良,等。胡黄连苷11对大鼠脑缺血再灌注损伤的干预作用.解剖学报,2010,41(1):9-12.IF=0.805
    35. Sun L, Fang L, Wang L, et al. The anti-oxidant effect and the possible mechanism of picroside Ⅱ in cerebral ischemia reperfusion injury in rats. Neural Regen Res, 2011,6(15):1141-1146.
    1 Watson BD; Prado R; Veloso A. Cerebral blood flow restorationand reperfusion injury after ultraviolet laser-facilitated middle cerebral artery recanalization in rat thrombotic stroke.2002(02)
    2 Wang LC; Futrell N; Wang DZ A. reproducible model of middle cerebral infarcts, compatible with long-term survival in aged rats.1995(11)
    3 Dietrich WD; Busto R; Watson BD. Photochemically induced cerebral infarction I early microvascular alterations.1987
    4 Dietrich WD;Busto R;Watson BD Photochemically induced cerebral infarction II edema and blood brain barrier disruption.1987
    5 Takeda A;Onodera H;Sugimoto A Induction of heparin-binding growth-associated molecule expression in reactive astrocytes following hippocampal neuronal injury. 1995(01) DOI:10.1016/0306-4522(95)00110-5
    6 Hond AS; Kagoshima M; Wanaka A Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain:Implication as neurotrophic factor.1997(02)
    7 Petito CK; Chung MC; Verkhovsky LM. Brain glutamine synthetase increase following cerebral ischemia in the rat. DOI:10.1016/0006-8993(92)90639.
    8 Lipton P Ischemic cell death in brain neurons. Physiol Sev,1999;79(4):1431-568
    9李敬诚,董为伟.脑缺血后细胞凋亡及其基因研究.脑血管疾病基础与临床研究进展.重庆:重庆大学出版社,1998:18~31.
    10 Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis[J]. Ccancer Res,1997,57(100):1835-1840.
    11朱铁年,赵瑞景,凌亦凌.多聚(ADP-核糖)聚合酶与细胞损伤.中国病理生理杂志.2002,18(1):104-107
    12罗玉敏,Chen Jun,秦震.脑缺血与DNA损伤.国外医学脑血管疾病分册,2002,8(5):259-261.
    13 Jackson SP. The recognition of DNA damage. Curr Opin Genet Dev,1996,6:19-25
    14 Mehmet H, Yue X, Squier MV, et al. Increased apoptosis in the cingulated sulcus of newbom piglets following transient hypoxia-ischaemia is related to the degree of high energy phosphate depletion during the insult[J]. Neurosci.Lett,1994, 181(1-2):121-125
    15 SzaboC, Dawson VL. Role of poly (ADP-Ribose) synthetase in inflammation and ischemia-reperfusion. Trends pgarmacol Sci,1998,19(7):287-298.
    16 Conde C, Mark M, Oliver FJ, et al.Loss of poly(ADP-ribose)polymerase-1 causes increased tumor lattency in p53-deficient mice. EMBOJ,2001,20(13):3535-3543.
    17 Lo EH, Bosque Hamilton P, Meng W. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl- D-aspartate- induced-neurotransmitter dysregulation.Stroke,1998,29:830-836.
    18 Szabo C. DNA strand breakage and activation of poly ADP ribosyltrans ferase:a cytotoxic pathway triggered by peroxynitrite. Free Radio Biol Med,1996,21: 855-869.
    19 Ou BR, Forsberg NE.Determination of skeletal muscle, Calpain and Calpainstatin activities during maturation. Am J Physiol,1991,261(6):677-683
    20肖小华,黄如训.卡配因及其抑制剂在脑缺血中的作用.国外医学脑血管疾病分册.1999,7(4):195-196.
    21邓志宽,董为伟.卡配因与缺血性脑损伤.国外医学脑血管疾病分册2002,10(3):223-224
    22 Yoshida M, Yamashima T, Zhao L, et al. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol(Berl), 2002,104(3):267-72
    23 Fukuda T, Adachi E, Kawashima S, et al. Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus. J Comp N eurol,1990,302:100.
    24 Ziemka-Nalecz M, Zalewska T, Zajac H, et al. Decrease of PKC precedes other cellular signs hippocampus after transient cerebral ischemia. Neurochem Int 2003 Feb;42(3):205-14
    25 Hong SC, Goto Y, Lanzino G, et al. Neuroprotection with a Calpain inhibitor in a model of focal cerebral ischemia. Stroke,1994,25:663-6693
    26 KimJ W, Won J, SohnS, et al. DNA-binding activity of the N-terminal cleavage product of poly (ADP-ribose) polymerase is required for UV mediated apoptosis. J of cell sci,2000,113(pt6):955-961.
    27 Le Rhun Y. Celluar responses to DNA damage in the absence of Poly(ADP-ribose) polymerase.Biochem Biophys. Res Commun,1998,245:1-10.
    28 Griffin RJ.The role of inhibitors of Poly(ADP-ribose)polymerase as resistance modifying agents in cancer therapy.Biochimie,1995,77:408-422.
    29 Jackson SP. The recognition of DNA damage. Curr Opin Genet Dev,1996,6:19-25
    30 32. Schaller B. Prospects for the future:the role of free radicals in the treatment of stroke. Free Radic Biol Med,2005,38(4):411-425.
    31 33. Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci,2008,28(26):2221-2230.
    32 34. Bi X, Yan B, Fang S et al. Quetiapine regulates neurogenesis in ischemic mice by inhibiting NF-kappaB p65/p50 expression. Neurol Res,2009,31(2):159-166.
    33 35. Chakravarty S, Herknham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. Neurosci,2005,25:1788-1796.
    34 36. Zee RY, Hegener HH, Gould J, et al. Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke,2005,36(1):154-157.
    35 37 Khan M, Sekhon B, Giri S, et al. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab,2005,25(2):177-192.
    36 38. Kokkinopoulos I, Jordan WJ, Ritter MA.Toll-like receptor mRNA expression patterns in human dendritic cells and monlcytes. Mol Immunol,2005,42(8):957-960.
    37 39. Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci,2008,28:2221-2230.
    38 40. Chen YH, Xu DX, Wang JP, et al. Melatonin protects against lipopolysaccharide induced intrauterine fetal death and growth retardation in mice. J Pineal Res, 2006,40:40-47.
    39 41. Caso JR, Pradillo JM, Hurtado O, et al. Toll-like receptor 4 is involved in subacute stress- induced neuroinflammation and in the worsening of experimental stroke. Stroke,2008,39(4):1314-1320.
    40 42. Hua F, Ma J, Ha T, et al. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia reperfusion injury in mice. Brain Res,2009,1262:100-108.
    41 43. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harbor Perspect Biol,2009,1 (4):a000034
    42 44. Courtois G, Gilmore TD. Mutations in the NFκB signaling pathway:Implications for human disease. Oncogene,2006,25(51):6831-6843.
    43 45. Boersma MC, Meffert MK, et al. Novel roles for the NFκB signaling pathway in regulating neuronal function. Sci Signal,2008,1(6):pe7.
    44 46. Liu Y, Zhang XJ, Yang CH, et al. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NFκB expression. Brain Res, 2009,1268:174-180.
    45 47. Webster CM, Kelly S, Koike MA, et al. Inflammation and NFκB activation is decreased by hypothermia following global cerebral ischemia. Neurobiol Dis, 2009,33(2):301-312.
    46 48. Zhang HL, Gu ZL, Savitz SI, et al. Neuroprotective effects of prostaglandin A in rat models of permanent focal cerebral ischemia are associated with nuclear factor kappaB inhibition and peroxisome proliferator activated receptor-gamma upregulation. J Neurosci Res,2008,86(5):1132-1141.
    47 49.何靖康,顾振纶,秦正红,等PGA1对缺氧再给氧大鼠心脏微血管内皮细胞ICAM-1表达的影响.中国药理学通报,2005,21(2):194-197.
    4 850.任德成,杜冠华,张均田.总丹酚对脑缺血再灌注损伤的保护作用.中国药理学通报,2002,1 8(3):275-277.
    49 51.刘启功,孙玉梅,程燕子,等.丹参注射液限制犬心肌梗死范围及其机制研究.中国药理学通报,2005,21(9):1078-1081.
    50 52.中华人民共和国药典委员会.中华人民共和国药典第一部.广东科技出版社,1995:204.
    51 53. Rastogi R, Srivastava AK, Rastogi AK, et al. Biochemical changes induced in liver and serum of aflatoxin B1-treated male Wistar rats:preventive effect of picroliv. Pharmacol Toxicol,2001,88(2):53-58.
    52 54.刘同华,黄林清,王军,等.西藏胡黄连提取物对小鼠实验性化学肝损伤的降酶作用.消化外科,2005,3(3):193-195.
    53 55. Tao YW, Liu JW, Wei DZ, et al. Protective effect of picroside II on the damage of culture PC12 cells in vitro. Chin J Clin Pharmacol Ther,2003,8(1):27-30.
    54 56. Liu JW, Yu YJ, Zheng PY, et al. Synergistic protective effect of picroside Ⅱ and NGF on PC12 cells against oxidative stress induced by H2O2. Pharmacol Rep,2007, 59(5):573-579.
    55 57. Li T, Liu JW, Zhang XD, et al. The neuroprotective effect of picroside Ⅱ from hu-huang-lian against oxidtive stress. Am J Chin Med,2007,35(4):681-691.
    5658. Guo MC, Cao Y, Liu JW, et al. Protective effects of picroside Ⅱ on glutamate injury of PC 12 cells. Chin J Clin Pharmacol Ther,2007,12(4):440-443.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700